Fig. 2. Residual error plots as a measure of performance for the revised pharmacokinetic model in (A ) the learning group (n = 19) and (B ) the test group (n = 10), expressed as measured/predicted plasma propofol concentrations over time during the infusion and postinfusion periods. For each subject, solid lines depict the infusion period and dashed lines, the postinfusion period.